PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsCipla
Cipla
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AbacavirAbacavir2017-11-212027-2029
Abacavir lamivudineAbacavir, Lamivudine2017-03-282027-2036
AcyclovirAcyclovir2019-01-182027-2030
AlbendazoleAlbendazole2018-09-21
AlbuterolAlbuterol2020-04-082024-2041
Albuterol ipratropiumAlbuterol, Ipratropium2007-12-312024-2041
AlendronateAlendronate2008-08-042031
AlfuzosinAlfuzosin2012-01-17
AmantadineAmantadine2016-09-302025-2038
AmbrisentanAmbrisentan2019-04-262027-2031
Amlodipine besylateAmlodipine besylate2007-09-26
—
AnastrozoleAnastrozole2010-06-28
1
2
3
4
5
6
...
11
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Budesonide
Lamivudine
Albuterol
Arformoterol
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use